The CNV values obtained from ddPCR analysis in advanced prostate cancer patient groups exhibited significant two-cluster groups between normal and deletion for both BRCA1 and BRCA2, as shown in Figure 5C,D. The gene discussed is BRCA1; the disease is prostate carcinoma.